Workplace-based cardiovascular risk management by community pharmacists: Impact on blood pressure, lipid levels, and weight

Pharmacotherapy

Volumn 26, Issue 10, 2006, Pages 1511-1517

  John, Elizabeth J ^a   Vavra, Theresa ^a   Farris, Karen ^a   Currie, Jay ^a   Doucette, William ^a   Button Neumann, Brenna ^b   Osterhaus, Matt ^c   Kumbera, Patty ^d   Halterman, Tom ^d   Bullock, Tammy ^c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c Osterhaus Pharmacy   (United States)

^d Outcomes Pharmaceutical Health Care   (United States)

Author keywords

Cardiovascular disease; Community pharmacy; Workplace

Indexed keywords

LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PHARMACIST; RURAL AREA; SYSTOLIC BLOOD PRESSURE; WEIGHT REDUCTION; WORKPLACE;

ADULT; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CASE MANAGEMENT; DIABETES COMPLICATIONS; FEMALE; HEALTH EDUCATION; HUMANS; INDUSTRY; IOWA; LIPIDS; MALE; MIDDLE AGED; OCCUPATIONAL HEALTH SERVICES; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PHARMACIES; PHARMACISTS; PROGRAM EVALUATION; RETROSPECTIVE STUDIES; RISK FACTORS; RISK MANAGEMENT; RURAL HEALTH SERVICES; WORKPLACE;

EID: 33749492731     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.26.10.1511     Document Type: Article

References (38)

1. American Heart Association. Heart disease and stroke statistics: 2005 update. Available from http://www. americanheart.org/downloadable/heart/ 1105390918119 HDSStats2005Update.pdf. Accessed August 18, 2005.
2. Qureshi AI, Suri MFK, Kirmani JF, Divani AA. The relative impact of inadequate primary and secondary prevention on cardiovascular mortality in the United States. Stroke 2004;35:2346-50.
3. American Heart Association. Risk factors and coronary heart disease. Available from http://www.americanheart.org/ presenter.jhtml?identifier=4726. Accessed November 7, 2005.
4. Till LT, Voris JC, Horst JB. Assessment of clinical pharmacist management of lipid lowering therapy in a primary care setting. J Manag Care Pharm 2003;9(3):269-73.
5. Murray MD, Young JM, Morrow DG, et al. Methodology of an ongoing, randomized, controlled trial to improve drug use for elderly patients with chronic heart failure. Am J Geriatr Pharmacother 2004;2(1):53-65.
6. Donaldson AR, Andrus MR. Pharmacist-run lipid management program in rural Alabama. Am J Health Syst Pharm 2004;61:493-7.
7. Bozovich M, Rubino CM, Edmunds J. Effect of a clinical pharmacist-managed clinic on achieving national cholesterol education program low-density lipoprotein goals. Pharmacotherapy 2000;20(11):1375-83.
8. Geber J, Parra D, Beckey NP, Korman L. Optimizing drug therapy in patients with cardiovascular disease: the impact of pharmacist-managed pharmacotherapy clinics in a primary care setting. Pharmacotherapy 2002;22(6):738-47.
9. Vivian EM. Improving blood pressure control in a pharmacist-managed hypertension clinic. Pharmacotherapy 2002;22(12): 1533-40.
10. Cording MA, Engelbrecht-Zadvorny EB, Pettit BJ, et al. Development of a pharmacist-managed lipid clinic. Ann Pharmacother 2002;36(5):892-904.
11. Ellis SL, Carter BL, Malone DC, et al. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Pharmacotherapy 2000;20(12):1508-16.
12. Okamoto MP, Nakahiro RK. Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic. Pharmacotherapy 2001;21(11);1337-44.
13. Shibley MCH, Pugh CB. Implementation of pharmaceutical care services for patients with hyperlipidemias by independent community pharmacy practitioners. Ann Pharmacother 1997;31:713-18.
14. Mangum SA, Kraenow KR, Narducci WA. Identifying at-risk patients through community pharmacy-based hypertension and stroke prevention screening projects. J Am Pharm Assoc (Wash) 2003;43(1):50-4.
15. Park JJ, Kelly P, Carter BL, Burgess PP. Comprehensive pharmaceutical care in the chain setting. J Am Pharm Assoc (Wash) 1996;NS36(7):443-51.
16. Carter BL, Barnette DJ, Chrischilles E, Mazzotti Gj, Asali ZJ. Evaluation of hypertensive patients after care provided by community pharmacists in a rural setting. Pharmacotherapy 1997;17(6):1274-85.
17. McKenney JM, Bradberry JC, Talbert RL, et al. National survey of pharmacists about coronary heart disease, hypercholesterolemia, nonprescription statin therapy, and pharmacists' services. J Am Pharm Assoc 2004;44(5):562-8.
18. Nola KM, Gourley DR, Portner TS, et al. Clinical and humanistic outcomes of a lipid management program in the community pharmacy setting. J Am Pharm Assoc 2000;40(2): 166-73.
19. McKenney JM, Brown ED, Necsary R, Reavis HL. Effect of pharmacist drug monitoring and patient education in hypertensive patients. Contemp Pharm Pract 1978;1:50-6.
20. Schnall PL, Landsbergis PA. Job strain and cardiovascular disease. Annu Rev Public Health 1994;15:381-411.
21. Alt RL. Where the boys are not: ahttp://www.medicinenet.com brief overview of male preventive health. Wisconsin Med J 2002;101(4):22-7.
22. Hing E, Middleton K. National hospital ambulatory medical survey: 2002 outpatient department summary. Advance data from vital and health statistics, no. 345, June 24, 2004, Centers for Disease Control and Prevention. Available from www.cdc.gov/nchs/data/ad/ad345.pdf. Accessed August 7, 2006.
23. Maquoketa, Iowa. Maquoketa, Iowa business data. Available from http://www.city-data.com/business/econ-Maquoketa-Iowa.html. Accessed August 18, 2005.
24. Smedslund G, Fisher KJ, Boles SM, Lichtenstein E. The effectiveness of workplace smoking cessation programmes: a meta-analysis of recent studies. Tobacco Control 2004;13: 197-204.
25. McMahon A, Kelleher CC, Helly G, Duffy E. Evaluation of a workplace cardiovascular health promotion programme in the Republic of Ireland. Health Promot Int 2002;17(4):297-308.
26. Guico-Pabia CJ, Cioffi L, Shoner LG. The Lucent-takes-heart cardiovascular health management program: successful workplace screening. AAOHN J 2002;50(8):365-72.
27. Heirich M, Sieck CJ. work site cardiovascular wellness programs as a route to substance abuse prevention. J Occup Environ Med 2000;42(1):47-56.
28. Kristensen TS. Workplace intervention studies. Occup Med 2000;15(1):293-305.
29. National Heart, Lung, and Blood Institute. Detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). NIH publication no. 02-5215. Bethesda, MD: National Institutes of Health, September 2002.
30. Barrett-Connor E, Wingard DL. Heart disease and diabetes. In: Diabetes in America. NIH publication no. 95-1468. Bethesda, MD: National Institutes of Health, 1995:429-56.
31. Expert Panel on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med 1998;158:1855-67.
32. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289(19):2560-72.
33. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. U.S. Department of Health and Human Services. 2004. Available from http://www.nhlbi.nih.gov/guidelines/ hypertension/jnc7full.pdf. Accessed September 28, 2005.
34. National Cholesterol Education Program. Cholesterol guidelines for adults (2001): the third report of the national cholesterol education program. Available from http://www. medicinenet.com. Accessed November 7, 2005.
35. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003;290:199-206.
36. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001;345(7):479-86.
37. Kivim̈ki M, Leino-Arjas P, Luukkonen R, Riihim̈ki H, Vahtera J, Kirjonen J. Work stress and risk of cardiovascular mortality: prospective cohort study of industrial employees [online exclusive article]. BMJ 2002;325:857. Available from http://bmj.bmjjournals.com/cgi/reprint/325/7369/857?eaf.
38. Schnall PL, Landsbergis PA, Baker D. Job strain and cardiovascular disease. Annu Rev Public Health 1994;15: 381-411.